“Beyond Glucose: Empagliflozin’s Impact on Fatty Liver in Patients With Type 2 Diabetes; A True Game Changer”. Indus Journal of Bioscience Research, vol. 3, no. 2, Feb. 2025, pp. 193-8, https://doi.org/10.70749/ijbr.v3i2.663.